BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11722917)

  • 1. Characterization of enterocoliticin, a phage tail-like bacteriocin, and its effect on pathogenic Yersinia enterocolitica strains.
    Strauch E; Kaspar H; Schaudinn C; Dersch P; Madela K; Gewinner C; Hertwig S; Wecke J; Appel B
    Appl Environ Microbiol; 2001 Dec; 67(12):5634-42. PubMed ID: 11722917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the efficacy of Enterocoliticin, a phage-tail like bacteriocin, as antimicrobial agent against Yersinia enterocolitica serotype O3 in a cell culture system and in mice.
    Damasko C; Konietzny A; Kaspar H; Appel B; Dersch P; Strauch E
    J Vet Med B Infect Dis Vet Public Health; 2005 May; 52(4):171-9. PubMed ID: 16000112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of enterocoliticin, a phage tail-like bacteriocin.
    Strauch E; Kaspar H; Schaudinn C; Damasko C; Konietzny A; Dersch P; Skurnik M; Appel B
    Adv Exp Med Biol; 2003; 529():249-51. PubMed ID: 12756766
    [No Abstract]   [Full Text] [Related]  

  • 4. Production of bacteriocin-like substances by Yersinia frederiksenii, Y. kristensenii, and Y. intermedia strains.
    Calvo C; Brault J; Ramos-Cormenzana A; Mollaret HH
    Folia Microbiol (Praha); 1986; 31(3):177-86. PubMed ID: 3758878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of bacteriocinogenic properties of Yersinia enterocolitica strains].
    Kot B; Bukowski K; Jakubczak A
    Med Dosw Mikrobiol; 1999; 51(1-2):91-101. PubMed ID: 10865435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriocin-like antagonism in Yersinia enterocolitica.
    Csiszár K; Tóth I
    Acta Microbiol Hung; 1992; 39(2):193-201. PubMed ID: 1284897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activity of chosen bacteriophages on Yersinia enterocolitica strains.
    Kot B; Bukowski K; Jakubczak A; Kaczorek I
    Pol J Vet Sci; 2002; 5(1):47-50. PubMed ID: 11944586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial purification and characterization of bacteriocin from Yersinia kristensenii.
    Toora S
    J Appl Bacteriol; 1995 Mar; 78(3):224-8. PubMed ID: 7730201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of plasmid regions of foodborne Yersinia enterocolitica biogroup 1A strains hybridizing to the Yersinia enterocolitica virulence plasmid.
    Hoffmann B; Strauch E; Gewinner C; Nattermann H; Appel B
    Syst Appl Microbiol; 1998 Jun; 21(2):201-11. PubMed ID: 9704108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriocin susceptibility of clinical Yersinia strains.
    Franzin L; Cabodi D; Fantino C
    Adv Exp Med Biol; 2003; 529():353-6. PubMed ID: 12756787
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rapid differentiation of the 0:3 and 0:9 serovars of Yersinia enterocolitica by certain bacteriophages].
    Calvo C; Fernandez A; Bejar V; Ramos Cormenzana A
    Ann Inst Pasteur Microbiol; 1987; 138(6):617-23. PubMed ID: 3454215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of bacteriocin-like antagonism by clinical isolates of Yersinia enterocolitica.
    Cafferkey MT; McClean K; Drumm ME
    J Clin Microbiol; 1989 Apr; 27(4):677-80. PubMed ID: 2723036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility and distribution of β-lactamase A (blaA) and β-lactamase B (blaB) genes in enteropathogenic Yersinia species.
    Bonke R; Wacheck S; Stüber E; Meyer C; Märtlbauer E; Fredriksson-Ahomaa M
    Microb Drug Resist; 2011 Dec; 17(4):575-81. PubMed ID: 21970627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial susceptibility of Yersinia enterocolitica and Yersinia pseudotuberculosis strains isolated from humans in Poland during 2004-2009].
    Szych J; Jakubczak A; Wardak S; Madajczak G
    Med Dosw Mikrobiol; 2009; 61(4):311-9. PubMed ID: 20201320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serogroup-related escape of Yersinia enterocolitica YopE from degradation by the ubiquitin-proteasome pathway.
    Hentschke M; Trülzsch K; Heesemann J; Aepfelbacher M; Ruckdeschel K
    Infect Immun; 2007 Sep; 75(9):4423-31. PubMed ID: 17606597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the usefulness of selected virulence markers for identification of virulent Yersinia enterocolitica strains. II. Genotypic markers associated with the pYV plasmid].
    Gierczyński R
    Med Dosw Mikrobiol; 2000; 52(1):35-49. PubMed ID: 11107778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of occurrence of virulence genes among Yersinia enterocolitica isolates belonging to different biotypes and serotypes.
    Kot B; Piechota M; Jakubczak A
    Pol J Vet Sci; 2010; 13(1):13-9. PubMed ID: 21077426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of Yersinia Enterocolitica Bacteriophage PhiYe-F10 Lysis Spectrum and Analysis of the Relationship between Lysis Ability and Virulence Gene of Yersinia Enterocolitica].
    Zha T; Liang J; Xiao Y; Jing H
    Bing Du Xue Bao; 2016 Mar; 32(2):185-9. PubMed ID: 27396162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenic potential of Yersinia enterocolitica 1A.
    Batzilla J; Heesemann J; Rakin A
    Int J Med Microbiol; 2011 Nov; 301(7):556-61. PubMed ID: 21798805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of pathogenic Yersinia enterocolitica serogroups by pulsed-field gel electrophoresis of genomic NotI restriction fragments.
    Saken E; Roggenkamp A; Aleksic S; Heesemann J
    J Med Microbiol; 1994 Nov; 41(5):329-38. PubMed ID: 7966205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.